58995-27-0

Basic information

• Product Name: 2,5-Pyrrolidinedione, 1-[1-oxo-3-[(triphenylmethyl)amino]propoxy]-
• CAS NO: 58995-27-0
• Molecular Formula: C26H24N2O4
• Molecular Weight: 428.488
• Mol File: 58995-27-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2,5-Pyrrolidinedione, 1-[1-oxo-3-[(triphenylmethyl)amino]propoxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-Pyrrolidinedione, 1-[1-oxo-3-[(triphenylmethyl)amino]propoxy]-(58995-27-0)
• EPA Substance Registry System: 2,5-Pyrrolidinedione, 1-[1-oxo-3-[(triphenylmethyl)amino]propoxy]-(58995-27-0)

Safety Data

• Hazardous Substances Data: 58995-27-0(Hazardous Substances Data)

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 58995-30-5 N-trityl-β-alanine 

Downstream Products

• 450409-20-8 1-[3-(trityl-amino)-propyl]-[1,6]diazecane-2,5-dione 
• 334513-03-0 N₁-tritylspermidine 
• 89448-83-9 3-N-tritylamino-1-propanol 
• 812653-37-5 N,N'-bis-[3-(trityl-amino)-propyl]-9H-fluorene-3,6-diamine 
• 812653-36-4 N-trityl-N'-(4-{4-[3-(trityl-amino)-propylamino]-benzyl}-phenyl)-propane-1,3-diamine 
• 812653-26-2 3-(trityl-amino)-N-(4-{4-[3-(trityl-amino)-propionylamino]-benzyl}-phenyl)-propionamide 
• 812653-27-3 3-(trityl-amino)-N-{6-[3-(trityl-amino)-propionylamino]-9H-fluoren-3-yl}-propionamide 
• 450409-29-7 3-(trityl-amino)-N-(4-{[3-(trityl-amino)-propionyl]-[3-(trityl-amino)-propyl]-amino}-butyl)-N-[3-(trityl-amino)-propyl]-propionamide 
• 443770-15-8 3-(trityl-amino)-N-[4-(trityl-amino)-butyl]-propionamide 
• 211632-82-5 N-benzyl-N'-tritylpropane-1,3-diamine 
• 211632-83-6 [2-(Benzyl-{4-[3-(trityl-amino)-propionylamino]-butyl}-carbamoyl)-ethyl]-carbamic acid 9H-fluoren-9-ylmethyl ester 

Relevant articles and documents

NEW N-AMINO ACID DERIVATIVES OF DAUNORUBICIN

New N-amino acid derivatives of daunorubicin have been obtained by acylation of daunorubicin amino group with α, β and γ amino acids and their N,N-dibenzyl derivatives.The results of the antitumor activity determination have evidenced that the change of the amino function position in the daunorubicin derivatives, in relation to that of the parent antibiotic, causes the loss of activity.